Programmed death‐ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2‐negative status

Gastric cancer (GC) is one of the most common malignancies. Immunotherapy is a promising targeted treatment. The immune regulatory programmed death‐1 (PD‐1)/programmed death‐ligand 1 (PD‐L1) axis has been used as a checkpoint target for immunotherapy. Currently, considerable discrepancies exist conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lei, Zhang, Qiongyan, Ni, Shujuan, Tan, Cong, Cai, Xu, Huang, Dan, Sheng, Weiqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010739/
https://www.ncbi.nlm.nih.gov/pubmed/29673110
http://dx.doi.org/10.1002/cam4.1502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010739/
https://www.ncbi.nlm.nih.gov/pubmed/29673110
http://dx.doi.org/10.1002/cam4.1502

Ejemplares similares